<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04430621</url>
  </required_header>
  <id_info>
    <org_study_id>FSH1</org_study_id>
    <nct_id>NCT04430621</nct_id>
  </id_info>
  <brief_title>Effects of FSH on Endothelial Function (FEND)</brief_title>
  <acronym>FEND</acronym>
  <official_title>Effects of Follicle-Stimulating Hormone Injection on Flow Mediated Dilation in Healthy Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study will be to evaluate the effects of the s.c. administration of 300 IU of
      FSH in 16 healthy males. The endothelial function will be evaluated by the measurement with
      ecographic approach of the flow mediated dilation (FMD) of the brachial artery. The FMD will
      be measured before and 6, 12, 24 or 48 hours after FSH or placebo adiministration in the same
      subjects studied 2 weeks apart. The results will help to clarify whether perturbation of FSH,
      similar to the one observed in women after the menopause, affect endothelial function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effects of follicle-stimulating hormone (FSH) have been poorly studied. In women, FSH is
      involved in estrogen production, while in men regulates spermatogenesis. On the other hand,
      in women, menopause is associated with an increase in the risk of cardiovascular disease and
      the concentration of FSH rises. It is unclear whether such an increase has any effect on the
      development of atherosclerosis. Endothelial dysfunction represents an early trigger of
      atherosclerosis. Since estrogens can directly stimulate endothelial function and increase in
      response to FSH administration, males might represent a potential model to study the effcts
      of FSH independent from estrogens.Purpose of the study will be to evaluate the effects of the
      s.c. administration of 300 IU of FSH in 16 healthy males. The endothelial function will be
      evaluated by the measurement with ecographic approach of the flow mediated dilation (FMD) of
      the brachial artery. The FMD will be measured before and 6, 12, 24 or 48 hours after FSH or
      placebo adiministration in the same subjects studied 2 weeks apart. The results will help to
      clarify whether perturbation of FSH, similar to the one observed in women after the
      menopause, affects endothelial function.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in flow mediated dilation</measure>
    <time_frame>before and 48 hours after FSH or placebo administration</time_frame>
    <description>Evaluation of endothelial function of the brachial artery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Change in Flow Mediated Dilation</condition>
  <arm_group>
    <arm_group_label>FSH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FSH, 300 IU s.c.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, s.c.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Follicle Stimulating Hormone</intervention_name>
    <description>FSH will be administered s.c. in the morning to male healthy subjects</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>FSH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Healthy volunteers -

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaele Napoli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Federico II</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raffaele Napoli, MD</last_name>
    <phone>+390817463736</phone>
    <email>napoli@unina.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Internal Medicine and Diabetes Unit</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaele Napoli, MD</last_name>
      <phone>+390817463736</phone>
      <email>napoli@unina.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>RAFFAELE NAPOLI</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>endothelial function, atherosclerosis, FSH, FMD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

